How much calcium is in your drinking water? A survey of calcium concentrations in bottled and tap water and their significance for medical treatment and drug administration

HSS Journal

Volumn 2, Issue 2, 2006, Pages 130-135

  Morr, Simon ^a   Cuartas, Esteban ^b   Alwattar, Basil ^c   Lane, Joseph M ^a,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bioavailability; Bisphosphonate; Calcium supplements; Filter; Water

Indexed keywords

EID: 33748314538     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-006-9000-9     Document Type: Review

References (29)

1. Reid IR, Ames RW, Evans MC et al (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J 328:460-464
2. Shea B, Wells G, Cranney A et al (2002) Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23:552-559
3. National Institutes of Health (1994) Optimal calcium intake. NIH Consens Statement 12:1-31
4. Dawson-Hughes B (1998) Vitamin D and calcium: recommended intake for bone health. Osteoporos Int 8:S30-S34
5. Nordin BEC (2000) Calcium requirement is a sliding scale. Am J Clin Nutr 71:1381-1383
6. Dawson-Hughes B, Harris S, Krall E et al (1997) Effect of calcium and vitamin-D supplementation on bone density in men and women 65 years or age or older. N Engl J Med 337:670-676
7. Wu DD, Boyd RD, Fix TJ et al (1990) Regional patterns of bone loss and altered bone remodeling in response to calcium deprivation in laboratory rabbits. Calcif Tissue Int 47:18-23
8. Espallargues M, Sampietro-Colom L, Estrada MD et al (2001) Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 12:811-822
9. National Institutes of Health (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17:1-45
10. Valtin H (2002) "Drink at least eight glasses of water a day." Really? Is there scientific evidence for "8 × 8"?. Am J Physiol Regul Integr Comp Physiol 283:R993-R1004
11. Böhmer H, Müller H, Resch KL (2000) Calcium supplementation with calcium-rich mineral waters: a systematic review and meta-analysis of its bioavailability. Osteoporos Int 11:938-943
12. Janner M, Muhlbauer RC, Fleisch H (1991) Sodium EDTA enhances intestinal absorption of two bisphosphonates. Calcif Tissue Int 49:280-283
13. Hosking D, Chilvers CED, Christiansen C et al (1998) Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 228:485-492
14. Lieberman UA, Weiss SR, Bröll J et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443
15. Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604-610
16. Saag KG, Emkey R, Schnitzer T et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292-299
17. Devogelaer JP, Broll H, Correa-Potter R et al (1996) Oral alendronate induced progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141-150
18. Black DM, Cummings SR, Karpf DB et al (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541
19. Lin JH (1996) Bisphosphonates: review of their pharmacokinetic properties. Bone 18:75-85
20. Rodan GA, Seedor JG, Balena R (1993) Preclinical pharmacology of alendronate. Osteoporos Int 3:S7-S12
21. Dunn CJ, Goa KL (2001) Risedronate, a review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 61:685-712
22. Porras AG, Holland SD, Gertz BJ (1999) Pharmacokinetics of alendronate. Clin Pharmacokinet 36:315-328
23. Laitinen K, Patronen A, Harju P et al (2000) Timing of food intake has a marked effect on the bioavailability of clodronate. Bone 27:293-296
24. Merck and Co. Fosamax® Alendronate Sodium (Prescribing Information). Downloaded from Fosamax.com on July 7, 2003
25. P&G Pharmaceuticals. Actonel® Risendronate Sodium (Prescribing Information) Downloaded from Actonel.com on July 7, 2003
26. Brown TL, LeMay HE, Bursten BE et al (2003) Chemistry: The Central Science Ninth edition Upper Saddle River, New Jersey Prentice Hall, p. 684.
27. Sheikh MS, Santa Ana CA, Nicar MJ et al (1987) Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 317:532-536
28. Heaney RP, Dowell MS, Barger-Lux MJ (1999) Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporos Int 9:19-23
29. Rozen GS, Rennert G, Dodiuk-Gad RP et al (2003) Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. Am J Clin Nutr 78:993-998